CTIM-76
CNTX-CTIM76-101
Phase 1 small_molecule active
Quick answer
CTIM-76 for Platinum-resistant Ovarian Cancer is a Phase 1 program (small_molecule) at Context Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Context Therapeutics
- Indication
- Platinum-resistant Ovarian Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active